Parkinson's Disease

Parkinson’s disease is one of the many diseases Congresswoman Maloney hopes will reap the benefits of federally funded medical research. The Congresswoman has worked hard to combat Parkinson’s disease by fighting for federal funding to support research on the disease as well as increasing public awareness of the effects of Parkinson’s on millions of Americans.

Parkinson's disease is a progressive degenerative brain disease which kills a specialized and vital type of brain cell. This cell produces the substance dopamine, which is essential for normal movement and balance. As the disease progresses, it inflicts horrific physical, emotional, and financial burdens on the patient and family, requiring the caregiver to assist in the activities of daily living, and may eventually lead to placement in a nursing home until death. With further research into stem cells, scientists will be able to "reprogram" the stem cells into the dopamine-producing cells which are lost in Parkinson's disease. Parkinson's disease affects at least one million Americans. Fifty-thousand people are diagnosed each year and for every person diagnosed, two who have Parkinson's disease are not diagnosed. It is imperative that Congress supports legislation that will go towards Parkinson’s research so that one day a cure may be found for this terrible and debilitating disease.

Congresswoman Maloney has also introduced legislation that calls for April to be Parkinson’s Awareness Month, and is the head of the Congressional Caucus on Parkinson’s Disease, which has been instrumental in securing more than $370 million in funding for the only Parkinson’s-specific program in the federal government – the Department of Defense’s Neurotoxin Exposure Treatment Research (NETRP) Program.

More on Parkinson's Disease

Jun 20, 2014 Press Release
WASHINGTON – House Co-Chairs of the Congressional Caucus on Parkinson’s Disease, Representatives Carolyn B. Maloney (D-NY), Peter King (R-NY) and Chris Van Hollen (D-MD), are urging the National Institutes of Health to do more to spur medical advancements in the treatment of Parkinson’s Disease. The lawmakers sent a letter to NIH Director Dr. Francis S. Collins to request that Parkinson’s be added to the next phase of the Accelerating Medicines Partnership (AMP) program, which would aid in the discovery of biomarkers that can help provide earlier diagnosis and drug development treat the disease.
Apr 11, 2013 Press Release

WASHINGTON, DC – Today, the co-chairs of the Congressional Caucus on Parkinson's Disease Reps. Carolyn Maloney (D-NY), Peter King (R-NY), and Chris Van Hollen (D-MD) introduced a resolution designating April as Parkinson’s Awareness Month. The resolution calls for continued research to find better treatments, and eventually, a cure for the disease. It also thanks the dedicated national, state, and local organizations, volunteers, researchers, and millions of Americans across the country working to improve the quality of life of persons living with Parkinson’s disease and their families.


Oct 25, 2006 Press Release

WASHINGTON, DC – Yesterday, on his nationally-syndicated radio show, right-wing host Rush Limbaugh accused Michael J. Fox, who suffers from Parkinson’s Disease, of acting and exaggerating his symptoms in recent television ads for pro-stem cell research candidates.